Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1002-1006

  Lee, H M ^a   Le, H ^a   Lee, B T ^a   Lopez, V A ^a   Wong, N D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Lung function; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SURVEYS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VITAL CAPACITY; WORLD HEALTH; YOUNG ADULT;

EID: 78449247102     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00042410     Document Type: Article

References (27)

1. Gluckman TJ, Baranowski B, Ashen MD, et al. A practical and evidence-based approach to cardiovascular risk reduction. Arch Intern Med 2004; 164: 1490-1500. (Pubitemid 38970467)
2. Thompson J, Rivera JJ, Blumental RS, et al. Primary prevention for patients with intermediate Framingham risk scores. Curr Cardiol Rep 2006; 8: 261-226. (Pubitemid 44043980)
3. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of CVD: The Framingham study. Am Heart J 1983; 105: 311-315.
4. Marcus EB, Curb JD, MacLean CJ, et al. Pulmonary function as a predictor of coronary heart disease.AMJ Epidemiol 1089; 129: 97-104.
5. Enstrom G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk, relation with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-2560. (Pubitemid 35340691)
6. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 159: 1171-1181. (Pubitemid 37548787)
7. Sin D, Wu LL, Man P. The relationship between reduced lung function and cardiovascular mortality. A population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
8. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh: respiratory symptoms, chronic respiratory disease and ventilatory lung function. Arch Environ Health 1970; 21: 418-424.
9. Beaty TH, Newill CA, Cohen BH, et al. Effects of pulmonary function on mortality. J Chronic Dis 1985; 38: 703-710.
10. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington county, Maryland. Am Rev Respir Dis 1989; 140: S56-S63.
11. Hole DJ, Watt GC, Darvey-Smith G, et al. Impaired lung function and mortality risks in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-715.
12. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long term predictor of mortality in the general population: 29 year follow-up of the Buffalo Health Study. Chest 2000; 118: 656-664.
13. Curb JD, Marcus EB, Reed DM, et al. Smoking, pulmonary function and mortality. Ann Epidemiol 1990; 1: 25-32.
14. Lange P, Nyboe J, Appleyard M, et al. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990; 43: 867-873.
15. Centers for Disease Control and Prevention (CDC) National Center for Health Statistics. Third National Health and Nutrition Examination Survey Data. Hyattsville, CDC, 1994.
16. Bernert JT, Turner WE, Pirkle JL, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997; 43: 2228-2291.
17. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatmeant of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002; 106: 3143-3421.
18. Centers for Disease Control and Prevention, National Center for Health Statistics. Third National Health and Nutrition Examination Survey laboratory/medical technologists procedures and manual. Hyattsville, CDC, 1994.
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
20. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). Third National Health and Nutrition Examination Linked Mortality File: Matching Methodology. Hyattsville, CDC, 2005.
21. Wilson PWF, Smith SC, Blumenthal RS, et al. Task Force #4 - How do we select patients for atherosclerosis imaging? In: 34th Bethesda Conference: can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease. J Am Coll Cardiol 2003; 41: 1898-1906.
22. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007; 49: 378-402.
23. Jiang R, Burke G, Enright P, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol 2008; 168: 602-610.
24. Thyagarajan B, Jacobs D, Apostol G, et al. Plasma fibrinogen and lung function: the Cardia study. Int J Epidemiol 2006; 35: 1001-1008. (Pubitemid 44540754)
25. Hancox R, Poulton R, Greene LM, et al. Systemic inflammation and lung function in young adults. Thorax 2007; 62: 1064-1068. (Pubitemid 350206198)
26. Shaaban R, Kony S, Driss F, et al. Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study. Respir Med 2006; 100: 2112-2120. (Pubitemid 44752671)
27. Forgarty AW, Jones S, Britton JR, et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007; 62: 515-520. (Pubitemid 46910130)